| Home

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Email Newsletters

Sign up for one of our email newsletters.

Daily Photo Galleries

Wednesday, March 14, 2012

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Stories

  1. Humane Society lifts quarantine on dogs at North Side shelter
  2. Uniontown teen charged in shooting of friend
  3. Penguins notebook: Dupuis’ intangibles provide 1st-line value
  4. Steelers veteran linebacker Harrison focused on stretch run
  5. Friends, family, history lure natives back to Western Pennsylvania
  6. Penguins co-owner Lemieux snuffs rumored rift with Crosby
  7. Starkey: Artie Rowell’s incredible odyssey
  8. Crosby scores twice, Malkin delivers OT goal as Penguins beat Blues
  9. Emotional send-off awaits Pitt seniors
  10. WXXP listeners, artists to recall ’80s indie-rock days at reunion show
  11. Puppies’ eyes glued shut, South Huntingdon animal shelter says